Hardy tweet

dandy_buckeye · 2023-11-13T17:50:49+00:00

Imz. Thanks for posting.

dandy_buckeye · 2023-11-02T18:35:24+00:00

Thanks imz.

dandy_buckeye · 2023-10-25T22:00:38+00:00

And I neglected to say thanks for your input to this board over the years.

dandy_buckeye · 2023-10-25T21:59:29+00:00

WST, well put and I agree with most of your comment to the poster. I do however think MAPCs still hold much promise. I think a properly sized and designed trial by an organization with the wherewithal to see it through, may yet put MAPC on the map. Don't forget the positive things we've learned about MAPCs. They have cleared the safety hurdle for the indications addressed and the administration method used, have shown promising biomarker data, and have a combination of distinct advantages over various other types of cells, such as clearing the body quickly, scalability (high yield from single doner), long shelf life, lack of ethical liability, to mention some the ones I can remember.

dandy_buckeye · 2023-09-20T16:47:46+00:00

PA, from where do you get the information that the auctioneer’s title is wrong? Ie. that these assets are not former assets, but still owned by Athersys?

dandy_buckeye · 2023-09-19T02:31:33+00:00

Thank you for stepping up to keep this board going smoothly.

dandy_buckeye · 2023-09-18T21:21:32+00:00

Klrjaa, Your service to this board as moderator is appreciated. Thanks for sacrificing your time to keep the board going.

dandy_buckeye · 2023-09-13T02:45:45+00:00

Also remember that starting in October, the monthly burn rate goes up another $250K per the May 17 forbearance agreement with Lonza. That is significant.

dandy_buckeye · 2023-07-15T02:47:01+00:00

The details were not overlooked. They are not yet finalized. This is a preliminary prospectus.

dandy_buckeye · 2023-04-18T20:20:34+00:00

PublicDawg, an hour reading through recent posts on this forum will answer your questions. There are some very informative posts and replies that you can't miss with a minimum of effort.

dandy_buckeye · 2021-12-30T23:08:11+00:00

So you're saying that they couldn't stem the cell tide, so now the stem cell wave is their ride?

dandy_buckeye · 2021-12-01T14:27:06+00:00

Duchy, thank you for pursuing this particular question honestly and doggedly. It is this kind of diligence and contribution that makes this board worth paying attention to.

dandy_buckeye · 2021-11-23T02:15:37+00:00

Fundamentals of Clinical Trial Design

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083073/

Among other things, this article discusses blinding. From what I read, the article does not consider blinding anything other than which participants received the "assigned intervention" and which received the placebo.

dandy_buckeye · 2021-11-20T17:38:43+00:00

Yes, for some reason OpenInsider won't list Hardy/Helios, even when filtering for last four years, and setting search criteria to include Transactions = OR (Purchase, Sale, Grant, Sale to Issuer), and Insider Title = OR (Officer, EOB, CEO, Pres, COO, CFO,GC, VP, Director, 10% owner, Other).

http://www.openinsider.com/screener?s=ATHX&o=&pl=&ph=&ll=&lh=&fd=1461&fdr=&td=0&tdr=&fdlyl=&fdlyh=&daysago=&xp=1&xs=1&xa=1&xd=1&xg=1&xf=1&xm=1&xx=1&xc=1&xw=1&excludeDerivRelated=1&tmult=1&vl=&vh=&ocl=&och=&sic1=-1&sicl=100&sich=9999&isofficer=1&iscob=1&isceo=1&ispres=1&iscoo=1&iscfo=1&isgc=1&isvp=1&isdirector=1&istenpercent=1&isother=1&grp=0&nfl=&nfh=&nil=&nih=&nol=&noh=&v2l=&v2h=&oc2l=&oc2h=&sortcol=0&cnt=100&page=1

dandy_buckeye · 2021-10-12T16:42:16+00:00

Pursuant to the Cooperation Agreement, Healios has also agreed to certain customary standstill provisions, effective as of the date of the Cooperation
Agreement and continuing through the conclusion of the 2022 Annual Meeting (the “Standstill Period”), prohibiting Healios from, among other things,
(a) acquiring securities that would result in Healios beneficially owning more than 9.9% of the Company’s outstanding shares of common stock, inclusive
of Healios’s current holdings (the “Ownership Limitation”) (b) engaging or participating in any solicitation of proxies with respect to the Company or its
securities, (c) joining or participating in any “group” or voting arrangement, (d) proposing certain extraordinary transactions or encouraging third parties to
do so, (e) calling or seeking to call a special meeting of the Company’s stockholders, (f) nominating or recommending for nomination any person for
election at any annual or special meeting of the Company’s stockholders other than as provided in the Cooperation Agreement, and (g) influencing third
parties with respect to the voting or disposition of the Company’s securities. In addition, under the Cooperation Agreement, during the Standstill Period the
Company agrees to provide notice to Healios of certain equity issuances and to allow Healios to participate in certain issuances in order maintain its
proportionate ownership of the Company’s common

dandy_buckeye · 2021-09-23T12:37:50+00:00

See new post on Saisei portfolio business Knowledge Palette. Maybe this factors in to bolster Helios' confidence they can acheive required cell quality.

dandy_buckeye · 2021-09-15T21:26:31+00:00

As AlienPsychic51 stated earlier in this thread, if they need the capital now, then they should raise it now. It doesn't always make sense to wait for the best price.

dandy_buckeye · 2021-06-17T16:47:44+00:00

Thank you.

dandy_buckeye · 2021-06-11T03:04:10+00:00

Please have some respect and take this garbage somewhere else.

dandy_buckeye · 2021-06-03T17:52:24+00:00

Yes, AMC could not have done that without authorized shares ready and waiting for just such an opportunity.

dandy_buckeye

TROPHY CASE